Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Physical and Psychosocial Recovery in the Year After Primary Treatment of Breast Cancer</title><author><name sortKey="Ganz, Patricia A" sort="Ganz, Patricia A" uniqKey="Ganz P" first="Patricia A." last="Ganz">Patricia A. Ganz</name><affiliation><nlm:aff id="aff1">From the School of Public Health; Jonsson Comprehensive Cancer Center; David Geffen School of Medicine; and Cousins Center for Psychoneuroimmunology; Semel Institute, University of California, Los Angeles, CA.</nlm:aff></affiliation></author><author><name sortKey="Kwan, Lorna" sort="Kwan, Lorna" uniqKey="Kwan L" first="Lorna" last="Kwan">Lorna Kwan</name><affiliation><nlm:aff id="aff1">From the School of Public Health; Jonsson Comprehensive Cancer Center; David Geffen School of Medicine; and Cousins Center for Psychoneuroimmunology; Semel Institute, University of California, Los Angeles, CA.</nlm:aff></affiliation></author><author><name sortKey="Stanton, Annette L" sort="Stanton, Annette L" uniqKey="Stanton A" first="Annette L." last="Stanton">Annette L. Stanton</name><affiliation><nlm:aff id="aff1">From the School of Public Health; Jonsson Comprehensive Cancer Center; David Geffen School of Medicine; and Cousins Center for Psychoneuroimmunology; Semel Institute, University of California, Los Angeles, CA.</nlm:aff></affiliation></author><author><name sortKey="Bower, Julienne E" sort="Bower, Julienne E" uniqKey="Bower J" first="Julienne E." last="Bower">Julienne E. Bower</name><affiliation><nlm:aff id="aff1">From the School of Public Health; Jonsson Comprehensive Cancer Center; David Geffen School of Medicine; and Cousins Center for Psychoneuroimmunology; Semel Institute, University of California, Los Angeles, CA.</nlm:aff></affiliation></author><author><name sortKey="Belin, Thomas R" sort="Belin, Thomas R" uniqKey="Belin T" first="Thomas R." last="Belin">Thomas R. Belin</name><affiliation><nlm:aff id="aff1">From the School of Public Health; Jonsson Comprehensive Cancer Center; David Geffen School of Medicine; and Cousins Center for Psychoneuroimmunology; Semel Institute, University of California, Los Angeles, CA.</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">21300931</idno><idno type="pmc">3083865</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083865</idno><idno type="RBID">PMC:3083865</idno><idno type="doi">10.1200/JCO.2010.28.8043</idno><date when="2011">2011</date><idno type="wicri:Area/Pmc/Corpus">002F38</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002F38</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Physical and Psychosocial Recovery in the Year After Primary Treatment of Breast Cancer</title><author><name sortKey="Ganz, Patricia A" sort="Ganz, Patricia A" uniqKey="Ganz P" first="Patricia A." last="Ganz">Patricia A. Ganz</name><affiliation><nlm:aff id="aff1">From the School of Public Health; Jonsson Comprehensive Cancer Center; David Geffen School of Medicine; and Cousins Center for Psychoneuroimmunology; Semel Institute, University of California, Los Angeles, CA.</nlm:aff></affiliation></author><author><name sortKey="Kwan, Lorna" sort="Kwan, Lorna" uniqKey="Kwan L" first="Lorna" last="Kwan">Lorna Kwan</name><affiliation><nlm:aff id="aff1">From the School of Public Health; Jonsson Comprehensive Cancer Center; David Geffen School of Medicine; and Cousins Center for Psychoneuroimmunology; Semel Institute, University of California, Los Angeles, CA.</nlm:aff></affiliation></author><author><name sortKey="Stanton, Annette L" sort="Stanton, Annette L" uniqKey="Stanton A" first="Annette L." last="Stanton">Annette L. Stanton</name><affiliation><nlm:aff id="aff1">From the School of Public Health; Jonsson Comprehensive Cancer Center; David Geffen School of Medicine; and Cousins Center for Psychoneuroimmunology; Semel Institute, University of California, Los Angeles, CA.</nlm:aff></affiliation></author><author><name sortKey="Bower, Julienne E" sort="Bower, Julienne E" uniqKey="Bower J" first="Julienne E." last="Bower">Julienne E. Bower</name><affiliation><nlm:aff id="aff1">From the School of Public Health; Jonsson Comprehensive Cancer Center; David Geffen School of Medicine; and Cousins Center for Psychoneuroimmunology; Semel Institute, University of California, Los Angeles, CA.</nlm:aff></affiliation></author><author><name sortKey="Belin, Thomas R" sort="Belin, Thomas R" uniqKey="Belin T" first="Thomas R." last="Belin">Thomas R. Belin</name><affiliation><nlm:aff id="aff1">From the School of Public Health; Jonsson Comprehensive Cancer Center; David Geffen School of Medicine; and Cousins Center for Psychoneuroimmunology; Semel Institute, University of California, Los Angeles, CA.</nlm:aff></affiliation></author></analytic><series><title level="j">Journal of Clinical Oncology</title><idno type="ISSN">0732-183X</idno><idno type="eISSN">1527-7755</idno><imprint><date when="2011">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec><title>Purpose</title><p>The 2000 National Institutes of Health Consensus Conference on Adjuvant Therapy of Breast Cancer recommended chemotherapy for all women with invasive cancer greater than 1 centimeter. Studies of long-term breast cancer survivors have found poorer quality of life (QOL) in women who received adjuvant chemotherapy. The aim of this article is to characterize physical and psychosocial recovery as a function of chemotherapy receipt in the year after medical treatment completion.</p></sec><sec><title>Patients and Methods</title><p>Prospective longitudinal survey data (RAND SF-36 and Breast Cancer Prevention Trial [BCPT] Symptom Scales) collected from 558 women with breast cancer enrolled on the Moving Beyond Cancer (MBC) psychoeducational intervention trial were compared according to receipt of chemotherapy. MBC study enrollment occurred within 4 weeks after the end of primary treatment (eg, surgery, chemotherapy, radiation). Self-report questionnaire data collected at enrollment and at 2, 6, and 12 months thereafter were examined, controlling for intervention and with propensity score adjustment for imbalance of covariates. Outcome analyses were carried out by fitting linear mixed models by using SAS PROC MIXED.</p></sec><sec><title>Results</title><p>Longitudinal SF-36 scale scores did not differ by chemotherapy treatment exposure, and both groups improved significantly (<italic>P</italic> < .01) in the year after primary treatment ended. However, adjuvant chemotherapy treatment was associated with significantly more severe physical symptoms, including musculoskeletal pain (<italic>P</italic> = .01), vaginal problems (<italic>P</italic> < .01), weight problems (<italic>P</italic> = .01), and nausea (<italic>P</italic> = .03).</p></sec><sec><title>Conclusion</title><p>Physical and psychosocial functioning improved significantly after breast cancer treatment, independent of receipt of adjuvant chemotherapy. Women who received chemotherapy experienced more severe and persistent physical symptoms that should be more effectively managed as part of survivorship care.</p></sec></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">J Clin Oncol</journal-id><journal-id journal-id-type="hwp">jco</journal-id><journal-id journal-id-type="pmc">jco</journal-id><journal-id journal-id-type="publisher-id">JCO</journal-id><journal-title-group><journal-title>Journal of Clinical Oncology</journal-title></journal-title-group><issn pub-type="ppub">0732-183X</issn><issn pub-type="epub">1527-7755</issn><publisher><publisher-name>American Society of Clinical Oncology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">21300931</article-id><article-id pub-id-type="pmc">3083865</article-id><article-id pub-id-type="publisher-id">88043</article-id><article-id pub-id-type="doi">10.1200/JCO.2010.28.8043</article-id><article-categories><subj-group subj-group-type="hwp-journal-coll"><subject>Bc5</subject><subject>Psc6</subject><subject>Psc12</subject><subject>Psc13</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Reports</subject><subj-group><subject>Breast Cancer</subject></subj-group></subj-group></article-categories><title-group><article-title>Physical and Psychosocial Recovery in the Year After Primary Treatment of Breast Cancer</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ganz</surname><given-names>Patricia A.</given-names></name><xref ref-type="aff" rid="aff1"></xref><xref ref-type="corresp" rid="cor1"></xref></contrib><contrib contrib-type="author"><name><surname>Kwan</surname><given-names>Lorna</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Stanton</surname><given-names>Annette L.</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Bower</surname><given-names>Julienne E.</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Belin</surname><given-names>Thomas R.</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><aff id="aff1">From the School of Public Health; Jonsson Comprehensive Cancer Center; David Geffen School of Medicine; and Cousins Center for Psychoneuroimmunology; Semel Institute, University of California, Los Angeles, CA.</aff></contrib-group><author-notes><corresp id="cor1">Corresponding author: Patricia A. Ganz, MD, Division of Cancer Prevention and Control Research, University of California, Los Angeles, Jonsson Comprehensive Cancer Center, A2-125 CHS, Box 956900, Los Angeles, CA 90095-6900; e-mail: <email>pganz@mednet.ucla.edu</email>.</corresp></author-notes><pub-date pub-type="ppub"><day>20</day><month>3</month><year>2011</year></pub-date><pub-date pub-type="epub"><day>7</day><month>2</month><year>2011</year></pub-date><pub-date pub-type="pmc-release"><day>20</day><month>3</month><year>2012</year></pub-date><pmc-comment> PMC Release delay is 12 months and 0 days and was based on the
<volume>29</volume><issue>9</issue><fpage>1101</fpage><lpage>1109</lpage><history><date date-type="received"><day>18</day><month>2</month><year>2010</year></date><date date-type="accepted"><day>3</day><month>11</month><year>2010</year></date></history><permissions><copyright-statement>© 2011 by American Society of Clinical Oncology</copyright-statement></permissions><self-uri xlink:title="pdf" xlink:type="simple" xlink:href="zlj00911001101.pdf"></self-uri><abstract><sec><title>Purpose</title><p>The 2000 National Institutes of Health Consensus Conference on Adjuvant Therapy of Breast Cancer recommended chemotherapy for all women with invasive cancer greater than 1 centimeter. Studies of long-term breast cancer survivors have found poorer quality of life (QOL) in women who received adjuvant chemotherapy. The aim of this article is to characterize physical and psychosocial recovery as a function of chemotherapy receipt in the year after medical treatment completion.</p></sec><sec><title>Patients and Methods</title><p>Prospective longitudinal survey data (RAND SF-36 and Breast Cancer Prevention Trial [BCPT] Symptom Scales) collected from 558 women with breast cancer enrolled on the Moving Beyond Cancer (MBC) psychoeducational intervention trial were compared according to receipt of chemotherapy. MBC study enrollment occurred within 4 weeks after the end of primary treatment (eg, surgery, chemotherapy, radiation). Self-report questionnaire data collected at enrollment and at 2, 6, and 12 months thereafter were examined, controlling for intervention and with propensity score adjustment for imbalance of covariates. Outcome analyses were carried out by fitting linear mixed models by using SAS PROC MIXED.</p></sec><sec><title>Results</title><p>Longitudinal SF-36 scale scores did not differ by chemotherapy treatment exposure, and both groups improved significantly (<italic>P</italic> < .01) in the year after primary treatment ended. However, adjuvant chemotherapy treatment was associated with significantly more severe physical symptoms, including musculoskeletal pain (<italic>P</italic> = .01), vaginal problems (<italic>P</italic> < .01), weight problems (<italic>P</italic> = .01), and nausea (<italic>P</italic> = .03).</p></sec><sec><title>Conclusion</title><p>Physical and psychosocial functioning improved significantly after breast cancer treatment, independent of receipt of adjuvant chemotherapy. Women who received chemotherapy experienced more severe and persistent physical symptoms that should be more effectively managed as part of survivorship care.</p></sec></abstract></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002F389 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 002F389 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé=
|texte=
}}
| This area was generated with Dilib version V0.6.31. |  |